Last updated on August 2019

A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies


Brief description of study

The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and severely active Crohn's disease (CD).

Clinical Study Identifier: NCT03345849

Find a site near you

Start Over

Facey Medical Foundation /ID# 203136

Mission Hills, CA United States
  Connect »

Ucsd /Id# 164910

San Diego, CA United States
  Connect »

Delta Waves, Inc. /ID# 164776

Colorado Springs, CO United States
  Connect »

Borland-Groover Clinic /ID# 203499

Jacksonville, FL United States
  Connect »

Advanced Research Institute /ID# 164921

New Port Richey, FL United States
  Connect »

DuPage Medical Group /ID# 205328

Downers Grove, IL United States
  Connect »

Aquiant Research /ID# 205503

New Albany, IN United States
  Connect »

Tri-State Gastroenterology /ID# 165496

Crestview Hills, KY United States
  Connect »

CroNOLA, LLC /ID# 164823

Houma, LA United States
  Connect »

NY Scientific /ID# 164931

Brooklyn, NY United States
  Connect »

Gastro One /ID# 164826

Germantown, TN United States
  Connect »

Sagact Pllc /Id# 169755

San Antonio, TX United States
  Connect »

Care Access Research /ID# 164794

Salt Lake City, UT United States
  Connect »

Cemic /Id# 169182

Buenos Aires, Argentina
  Connect »

Gedyt /ID# 210020

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Crchum /Id# 170120

Montreal, QC Canada
  Connect »

LLC Novaya Klinika /ID# 206616

Pyatigorsk, Russian Federation
  Connect »

PMI Euromedservice /ID# 206610

Pushkin, Russian Federation
  Connect »

Dr JP Wright /ID# 170887

Cape Town, South Africa
  Connect »